PRI-724 - PRISM Pharma, Ohara Pharma
|
WNT974 - Novartis
|
tegavivint (BC2059) - Iterion Therap
|
CWP-232291 - JW Pharma
|
OTSA101 - OncoTherapy
|
lorecivivint (SM04690) - Biosplice Therap, Samil Pharma
|
RXC004 - Redx
|
ETC159 - Experimental Therapeutics Centre
|
vantictumab (OMP-18R5) - Mereo Biopharma
|
CGX1321 - Curegenix
|